Laboratório de Química Bioorgânica, Instituto de Pesquisas de Produtos Naturais, Universidade Federal do Rio de Janeiro, 21941-902 Rio de Janeiro, Brazil
Auto-generated profile, based on publicly available information
Juliana de Oliveira Carneiro Brum
Laboratório de Química Bioorgânica, Instituto de Pesquisas de Produtos Naturais, Universidade Federal do Rio de Janeiro, 21941-902 Rio de Janeiro, Brazil
Hydrazones and their derivatives are very important compounds in medicinal chemistry due to their reported biological activity for the treatment of several diseases, like Alzheimer’s, cancer, inflammation, and leishmaniasis. However, most of the investigations on hydrazones available in literature today are directed to the synthesis of these molecules with little discussion available on their biological activities. With the purpose of bringing lights into this issue, we performed a revision of the literature and wrote this review based on some of the most current research reports of hydrazones and derivatives, making it clear that the synthesis of these molecules can lead to new drug prototypes. Our goal is to encourage more studies focused on the synthesis and evaluation of new hydrazones, as a contribution to the development of potential new drugs for the treatment of various diseases.
Six quinoline-piperonal hybrids were synthesized and evaluated as potential drugs against Alzheimer’s disease (AD). Theoretical analysis of the pharmacokinetic and toxicological properties of the compounds suggest that they present good oral bio-availability and are also capable of penetrating the blood–brain barrier, qualifying as leads for new drugs against AD. Evaluation of their inhibitory capacity against acetyl- and butyrilcholinesterases (AChE and BChE) through Ellmann’s test showed that three compounds present promising results with one of them being capable of inhibiting both enzymes. Further docking studies of the six compounds synthesized helped to elucidate the main interactions that may be responsible for the inhibitory activities observed.
The development of pharmacological agents for the treatment of Alzheimer's Disease (AD) is very relevant since this is the most common type of dementia. The inhibition of acetylcholinesterase (AChE) is important to increase the low levels of acetylcholine (ACh) neurotransmitter observed in sick people, which is associated with the memory loss. In this work, a new guanylhydrazone was designed and synthesized as an AChE inhibitor. This new compound was compared to tacrine and other guanylhydrazones. All of them were studied by molecular docking and tested in vitro as AChE inhibitors by Ellman's test and Fig-NMR method. A high inhibition of AChE by the new compound was observed, showing that this compound has great potential for the treatment of AD.
8 January 2021 in Journal of Biomolecular Structure and Dynamics
The acute respiratory syndrome caused by the SARS-CoV-2, known as COVID-19, has been ruthlessly tormenting the world population for more than six months. However, so far no effective drug or vaccine against this plague have emerged yet, despite the huge effort in course by researchers and pharmaceutical companies worldwide. Willing to contribute with this fight to defeat COVID-19, we performed a virtual screening study on a library containing Food and Drug Administration (FDA) approved drugs, in a search for molecules capable of hitting three main molecular targets of SARS-CoV-2 currently available in the Protein Data Bank (PDB). Our results were refined with further molecular dynamics (MD) simulations and MM-PBSA calculations and pointed to 7 multi-target hits which we propose here for experimental evaluation and repurposing as potential drugs against COVID-19. Additional rounds of docking, MD simulations and MM-PBSA calculations with remdesivir suggested that this compound can also work as a multi-target drug against SARS-CoV-2. Communicated by Ramaswamy H. Sarma
USE OF COAGULANTS IN THE TREATMENT OF HOSPITAL LAUNDRY EFFLUENT: THE SEARCH FOR SUSTAINABLE PHYSICAL-CHEMICAL PROCESSES TO REMOVAL POLLUTANTS AND PATHOGENIC MICROORGANISMS. Hospital laundry is an important source of environmental pollution because its effluent contains high loads of organic matter and microorganisms. Conventionally, the treatment is carried out using aluminum sulfate, a low-cost and highly efficient coagulant that is related to secondary contamination due to the generation of non-biodegradable sludge, its ability to accumulate metals and toxicity. Aiming for sustainable alternatives, the efficiency of tannin from the natural coagulant and Moringa oleifera seed was evaluated in relation to aluminum sulfate, seeking to adapt the color and turbidity parameters and determine the antimicrobial activity of the seed. Using a concentration of 100 mg L-1 of aluminum sulfate, 97.4 and 93.95% of color and turbidity removals in the effluent were obtained, respectively. With 50 mg L-1 tannin showed an efficiency of 84.96% for color removal and 89.75% for turbidity. Tests were also carried out with Moringa oleifera seeds using saline seed extract, crushed seeds and aqueous seed extract, with a reduction in conductivity by more than 99%, removing pollutant ions for the saline extract. Of the methodologies used, the best result was obtained with the aqueous extract, achieving removals of 89.63% of color, 78.33% of turbidity, and inhibition of more than 98.1% of microorganism growth.